Dr. Andreas Windemuth, Ph.D.
在加入Cyclica之前，Andreas曾担任Firefly BioWorks的首席信息官。Fireworks BioWorks是一家在麻省理工学院创建的生物技术公司，在那里他建立了公司多重测定技术的所有计算部分。 Andreas是Boehringer Ingelheim Fonds（德国斯图加特）的研究员，其博士后研究领域包括在国家超级计算应用中心和哥伦比亚大学进行的生物分子模拟 。 Andreas出版了60多篇同行评议的论文，并是7份美国专利的发明人。
Dr. Andy Hope, Ph.D.
在获得伦敦大学学院（UCL）化学博士学位后，Andy在计算机辅助分子设计领域的两所先驱公司里度过了他职业生涯的前十年：Chemical Design 和Biosym Technologies，（两家公司最终成为Accelrys的一部分，现在被称为Biovia ）。在Aspen Technology进一步工作了七年之后，他承担起的职务包括GeneFormatics业务发展总监，IBM Healthcare and Life Sciences解决方案执行总监，GeneGo（系统生物学）的业务发展总监， Thomson Reuters的发现与转化科学总监，以及在最近的Bio-ReferenceLabs / GeneDx的业务发展和战略联盟的高级总监。
Dr. Shane Climie, Ph.D.
在加入Cyclica之前，Shane在生命科学和制药行业拥有超过25年的研发和业务开发经验。他曾领导研究团队参与药物发现和技术开发的各个方面，并设计，协商和管理了许多研发合作项目。他在技术评估，技术开发和战略规划方面拥有丰富的经验。 Shane曾在波普尔公司担任过11年的主管，为早期生物技术公司提供临时执行管理服务，为诊断和药物发现/药物开发领域以及在业务管理，营销策略方面的支持技术或机会进行评估。在加入波普公司之前，Shane在Protana（以前的MDS Proteomics）担任过多个职务，包括科学战略与业务发展高级副总裁，研究合作高级副总裁，蛋白质组学与业务发展副总裁。 Climie博士也是MDS Ocata的联合创始人，副总裁兼首席技术官，也是Samuel Lunenfeld研究所的访问科学家。在此之前，Climie博士在Allelix Biopharmaceuticals, Inc. 担任过几个管理职务，包括首席科学家。 Climie博士在旧金山加州大学完成博士后研究，在多伦多大学获得医学生物物理学博士学位。
Scott Campbell, B.Sc.
Scott studied musical performance and composition at York University, Toronto. Following his studies in the Arts, Scott pursued his interests in computer programming and began to apply these skills professionally as a web developer.
Scott is in a band. That is all the detail he was willing to provide.
James Crompton, B.Sc.
James received his B.Sc and MSci from University College London (UCL) in Physics. During his Master’s he worked in one of UCL’s Atomic, Molecular, Optical and Positron Physics (AMOPP) labs studying the applications Optical Whispering Gallery modes in super precise inertial sensing.
James once ate everything on the dollar menu from McDonald’s in one sitting. Yeah, we worry about him too.
Steven Huang, B.Sc.
Steven is a graduate from UBC with a bachelor’s in Computer Science and Microbiology. Prior to working at Cyclica Steven has worked on a number of projects in Bioinformatics involving pattern matching and search optimization, as well as having worked with website development using Python. Steven is excited to be a part of Cyclica during this time of rapid growth and development.
Steven has a plethora of useless skills, the foremost of which is being good at gaming. You can usually find him somewhere on this page
Marc Laforet, M.Sc.
Marc received his Honors B.Sc. from Western University in both biochemistry and cell biology. He found his passion while conducting research, focusing his efforts on writing software to analyze biological data. Continuing as a M.Sc. candidate, Marc continued to utilize computation to implement cutting edge statistical analysis on biological data.
Marc grew up competing in the swimming pool, he was untouchable in the 100m butterfly
Dr. Stephen MacKinnon, Ph.D.
Director of R&D
Dr. MacKinnon received his Honors, Co-op, B.Sc. from the University of Waterloo in Computational Biochemistry, with placements in biotechnology industry and prestigious academic labs. He then completed a Ph.D. through the University of Toronto’s Department of Biochemistry and the Hospital for Sick Children. Throughout his thesis research, he crafted several highly specialized algorithms and computational pipelines to systematically analyze protein-protein and protein-ligand molecular interactions in search of new biological insights.
After substantial time in Germany and Nova Scotia, Stephen is a connoisseur in donair and doner kebab.
Dr. Steven Molinski, M.Sc., Ph.D.
He received his Hon.B.Sc. (Toxicology) from the University of Toronto, and M.Sc. (Pharmacology) from Queen’s University under the supervision of Dr. Susan P.C. Cole at the Queen’s Cancer Research Institute. He then completed his Ph.D. (Biochemistry) at the University of Toronto, under the supervision of Dr. Christine E. Bear at The Hospital for Sick Children. Steven’s research elucidated the molecular basis of disease for several rare Cystic Fibrosis mutations, as well as contributed to the development of novel high-throughput, cell-based screening methods to assist in drug discovery and precision medicine for individuals with this genetic disease. His graduate work has led to co-authorship on 11 peer-reviewed articles and one submitted patent application.
Steven has the largest collection of Boba Fett paraphernalia in Canada, and possibly the world.
Lenny studied Computer Science at the University of Waterloo. He maintains Cyclica's open source presence, as well as Styn, a Python build tool and fork of Pynt.
Lenny is learning to rock climb so he can assume his final form: Peter Parker.
Sonia Seto, M.Sc., M.Sc.BMC.
Sonia received her M.Sc. in Biomedical Communications from University of Toronto, specializing in interactive media used for developing engaging patient educational material. While in the program, she explored different ways to solve complex visual problems in science and medicine. Prior to that, she received her B.Sc. degree in Forensic Science from Trent University and her M.Sc. degree in Environmental & Life Sciences from Trent University. Her research focused on creating a DNA banking and database protocol for storing dry DNA samples at room temperature from endangered species.
Sonia is still patiently waiting for her letter from Hogwarts and wardrobe to Narnia.
Dr. Vijay Shahani, M.Sc.BMC., Ph.D.
Dr. Shahani received his Honors B.Sc from the University of Toronto in a joint biology and chemistry degree. He then completed a Ph.D. at the University of Toronto in the Department of Chemistry with a focus in medicinal chemistry. During the course of his research, he explored the interruption of a homo-dimeric proto-oncoprotein using small, rationally-designed molecules and their potential for therapeutic benefit. Vijay went on to complete a Master’s degree in biomedical communications at one of four accredited programs in North America. While at the BMC program, Vijay learned design concepts critical for creating data visualizations that aid in exploratory research and conducted cognitive research studies on an e-learning platform he developed.
Vijay was recently asked if he was in Grade 8 by one of his fellow beginner speed skating classmates. His facial hair assures otherwise.
Joseph Christian Somody, M.Sc.
Joseph received his Master of Science in Computational Biology and Bioinformatics in 2015 from ETH Zürich, where his thesis was centred on an investigation into the effect of reduced amino-acid alphabets on the classification of protein interfaces. Prior to that, in 2012, Joseph was awarded his Honours Bachelor of Science in Bioinformatics and Computational Biology by the University of Toronto. After returning to Canada from Switzerland, Joseph joined the team of Dr. Paul C. Boutros at the Ontario Institute for Cancer Research before starting at Cyclica Inc.
Joseph loves travelling, once cycled over 2000 kilometres from Budapest to Istanbul, and often brews his own beer.
Simon Song, B.Sc.
Simon studied Computer Science at the University of Toronto, where he specialized in Web and Internet Technologies and Artificial Intelligence. He implements and optimizes the Ligand Express™ pipeline and is performing detailed testing.
Simon’s goal this year is to collect all movie tickets of those he watched in theatres. He is aiming to beat his previous movie attendance record from 2016, a.k.a The Year of Million Kernels
Dr. Mostafa Analoui, Ph.D.
在加入Cyclica之前，Analoui博士在利文斯顿证券Livingston Securities担任医疗保健和生命科学部门的主管。他还在2001年至2008年2月担任辉瑞公司Pfizer Inc全球研究与开发全球临床技术的高级总监和Groton / New London分部的现场总监。在那里他领导了临床开发和商业部门的平台技术，包括计算医学的开发。他还是布朗大学和东北大学康涅狄格大学生物医学工程与创业教授。他曾担任Calando Pharmaceuticals，Inc.（称为Insert Therapeutics，Inc.），BPT Pharma，BEACON（生物医学工程联盟和CONSortium）以及NanoBusiness Alliance的董事会成员。 Analoui博士在生物医学和技术领域拥有极强地领导力。他积极参与纳米技术，药物发现/开发，诊断成像和全球战略的投资，管理和科学/业务发展。 Analoui博士撰写了130多篇出版物，包括期刊文章，书籍章节和技术报告。他拥有两项定量和临床成像专利。他已经获得博士学位，并接受了普渡大学和纽约州IBM TJ沃森研究中心的博士后研究金。
Michael T.R. List, J.D.
本世纪初，Michael共同创立了一家多国计算机硬件经销公司并担任首席运营官。 其后，他成为一所加拿大货币兑换公司的联合创始人兼首席运营官。该公司于成立两年半后出售。 Michael现任国际无晶圆半导体公司Smart Energy Instruments的总监兼总法律顾问。 Michael拥有皇后大学的法学学士学位，并且于2000年成为上加拿大律师协会的一员。
Dr. Shoshana Wodak, Ph.D.
Dr. Rick Panicucci, Ph.D.
Panicucci博士目前是药明康德药品开发副总裁，在可开发性，配方开发和GMP制造领域提供科学领导。在加入药明康德以前，他于2004年至2015年在诺华公司担任化学和药物分析全球主管（CPP）的职务，领导创新剂型设计和连续制造范例的开发和实施。他与Novartis BD&L and Venture Fund许多外部交易紧密合作，例如Proteus Digital Health，MicroChips，7th Sense Bio，West Pharma，Unilife，MIT和多伦多大学等等。 Panicucci医生目前担任马萨诸塞州药学院辅导教授。他的教育经历包括加州大学圣巴巴拉分校和安大略省癌症研究所两个博士后，以及多伦多大学的物理有机化学的博士学位。
Nathaniel Lipkus, J.D.
Nathaniel Lipkus在Osler律师事务所协助客户进行的业务涉及民事和知识产权，诉讼和政策事宜，涉及制药，药物知识产权，定价和报销，生物制品和防伪。 Nathaniel曾在加拿大专利诉讼上代表过软件和能源公司，品牌名称和仿制药制造商以及化学品供应商。他曾在加拿大联邦法院和联邦上诉法院以及安大略省高等法院和分区法院担任客户代表，在安大略省加拿大卫生和竞争局，美国食品药物管理局，联邦贸易委员会和美国国会前代表客户。Nathaniel于2006年毕业于多伦多大学法学院和罗特曼管理学院，并获得JD / MBA课程金奖。